2013
DOI: 10.1530/erc-13-0005
|View full text |Cite
|
Sign up to set email alerts
|

Wnt signalling in pituitary development and tumorigenesis

Abstract: Wnt signalling is activated in both pituitary organogenesis and its mature function. Wnt ligands and Wnt signalling pathways are critical for the regulation of the formation of the pituitary. In the mature pituitary, Wnt signalling pathways control cell activity and may stimulate cell proliferation in both physiological and pathological processes. This review compares Wnt signalling pathways active in the developing and mature pituitary and explores how this gives us further insight into the development of pit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
26
0
2

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 36 publications
(28 citation statements)
references
References 49 publications
0
26
0
2
Order By: Relevance
“…Increased expression of WNT4 has been observed in somatotropinomas, prolactinomas and thyrotropinomas when compared to normal pituitary tissue (Miyakoshi et al 2008, Chambers et al 2013. Since no change in subcellular β-catenin distribution was seen, it was proposed that the non-canonical WNT pathway is activated in these PIT1 lineage tumors, in agreement with WNT4 being a typical ligand in this pathway.…”
Section: Dysregulation Of Wnt In Pituitary Tumorigenesismentioning
confidence: 89%
See 1 more Smart Citation
“…Increased expression of WNT4 has been observed in somatotropinomas, prolactinomas and thyrotropinomas when compared to normal pituitary tissue (Miyakoshi et al 2008, Chambers et al 2013. Since no change in subcellular β-catenin distribution was seen, it was proposed that the non-canonical WNT pathway is activated in these PIT1 lineage tumors, in agreement with WNT4 being a typical ligand in this pathway.…”
Section: Dysregulation Of Wnt In Pituitary Tumorigenesismentioning
confidence: 89%
“…After translocation to the nucleus, β-catenin converts several transcriptional repressors, such as T-cell factor (TCF) 7 (previously called TCF1), TCF7-like 1 (TCF7L1, previously called TCF3), TCF7L2 (previously called TCF4) and lymphoid enhancer factor (LEF) 1, to activators by competing with corepressors like amino-terminal enhancer of split (AES) and transducin-like enhancer of split (TLE). The subsequent expression of downstream target genes like Axin2, Myc, Lef1 and CyclinD1 is often used as readout for the activation status of this canonical WNT/β-catenin pathway (Andoniadou et al 2013, Chambers et al 2013.…”
Section: :3mentioning
confidence: 99%
“…The Gene ontology and pathway analysis showed that these miRNAs are involved in regulation of developmental processes through targeting Wnt and TGF signaling. Wnt signaling is described to be activated in both pituitary organogenesis and its mature function [28]. In pituitary similarly to other tissue types Wnt signaling pathways control cell activity and may stimulate cell proliferation [28].…”
Section: Discussionmentioning
confidence: 99%
“…Aggressive NFPAs are difficult to resect completely, which often leads to tumor recrudescence (5). It is therefore important to identify the aggressiveness of NFPAs for selection of the appropriate (30)(31)(32)(33)(34). sFRPs have been identified as possible antagonists of the Wnt signaling pathway, and sFRP2, a member of the sFRPs family, has been associated with the degree of tumor malignancy and invasive ability of various types of human cancer (20,22).…”
Section: Discussionmentioning
confidence: 99%